Drug Price Transparency in Medicaid Act of 2023
- Introduced Mar 29
- Committee Mar 29
- Passed Senate Next
- Passed House Not yet
- To President Not yet
- Law Not yet
Where it stands
In committee, Mar 29, 2023Next: Senate vote
1309d ago Mar 29, 2023: Read twice and referred to the Committee on Finance.
Final votes
No roll callsNo recorded vote on this bill yet
Who backs the bill and who pushes back Subscribe
Companies lobbying on this bill
1 companyCompanies by sector
Consumer & Retail 1
Search all 1 companies, their asks and price moves Subscribe
Votes
No recorded roll-call vote on this bill yet
Member trades
Member trades around the votes Subscribe
Summary
Drug Price Transparency in Medicaid Act of 2023
Full summary1 paragraphs
This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions and survey participation to be made publicly available.
Library of Congress summary, Mar 29, 2023
Summary versions
- Introduced in SenateMar 29, 2023
Actions
- SenateIntroduced in SenateMar 29, 2023
- SenateRead twice and referred to the Committee on Finance.Mar 29, 2023
Bill record
Text versions1
- Introduced in SenateMar 29, 2023PDF: Introduced in Senate
Committees1
- Senate Finance CommitteeReferred To Mar 29, 2023
Sponsor and cosponsors3 cosponsors
- Sen. Peter Welch (D-VT)Sponsor, Mar 29, 2023
- Roger Marshall (R-KS)OriginalJoined Mar 29, 2023
- Shelley Capito (R-WV)Joined May 3, 2023
- Kirsten Gillibrand (D-NY)Joined Apr 30, 2024
Amendments0
No amendments offered
Cost estimates and reports0
No cost estimate or committee report yet
Titles2
Short titles
- Drug Price Transparency in Medicaid Act of 2023Short Title(s) as Introduced
Official titles
- A bill to amend title XIX of the Social Security Act to improve transparency and prevent the use of abusive spread pricing and related practices in the Medicaid program.Official Title as Introduced
Subjects13
Policy area
Legislative subjects
Business recordsCongressional oversightGovernment information and archivesHealth care costs and insuranceHome and outpatient careInflation and pricesMedicaidPrescription drugsPublic contracts and procurementRetail and wholesale tradesState and local government operationsUser charges and fees
Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.